Construction of a gE-Deleted Pseudorabies Virus and Its Efficacy to the New-Emerging Variant PRV Challenge in the Form of Killed Vaccine

Figure 6

Profile of PRV gB-specific (a), gE-specific (b), and neutralizing antibody (c) responses after vaccination.

(a)

(b)

(c)